The peanut-agglutinin (PNA)-binding surface components of malignant plasma cells

Area of Science:

• Hematology
• Immunology
• Glycobiology

Background:

• Plasma cells in multiple myeloma exhibit reactivity with peanut agglutinin (PNA).
• PNA is utilized for purging malignant cells in autologous bone marrow transplantation for multiple myeloma.
• Understanding PNA-binding proteins is crucial for refining therapeutic strategies.

Purpose of the Study:

• To isolate and characterize proteins from myeloma cells that bind to PNA.
• To investigate the role of CD44 glycosylation in PNA reactivity in multiple myeloma.

Main Methods:

• Affinity chromatography
• SDS-PAGE
• Immunoprecipitation
• Analysis of patient-derived myeloma cells

Main Results:

• A major PNA-binding protein identified in the Karpas-620 myeloma cell line was an incompletely sialylated form of CD44.
• CD44, typically fully sialylated and PNA-non-reactive, showed altered glycosylation in myeloma cells.
• Significant inter-patient variability in PNA-binding protein profiles was observed, with some patient cells lacking PNA-reactive CD44.

Conclusions:

• Multiple proteins contribute to PNA binding in malignant plasma cells.
• A novel, incompletely sialylated CD44 variant is present on myeloma cells.
• The functional implications of altered CD44 glycosylation in multiple myeloma pathogenesis require further investigation.